ARCHIVES

Agency Expands Gleevec Label To Include Rare GIST Subset

This article is from The Cancer Letter archive.

Vol. 35 No. 2 | February 24, 2012

Download PDF Visit The Full Archive

Related Articles

Capitol Hill: Bills Seeks Coverage for Treatment Of cancers Found in CDC Screening

April 2, 1999

No Difference in Toxicity Between IMRT and PRT In Medicare Patients

January 25, 2013

Research: No Increase in Cancer Deaths Found at Three Mile Island

May 5, 2000

No Cancer Letter For Two Weeks

August 10, 1990

Phase III Study Evaluating Halaven Fails To Meet Primary Endpoints

July 27, 2012

The Clinical Trials Working Group: NCI panel considers plan to centralize clinical trial review and prioritization. NCI director faults system for duplication, “equivocal results.”

August 13, 2004